Phase 3 Transverse Myelitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with NMOSD (Neuromyelitis Optica Spectrum Disorder).
- You have had at least 1 relapse (flare-up) of NMOSD in the past year, or at least 2 relapses in the past 2 years.
- If you are a woman who could become pregnant, your pregnancy test must be negative within 7 days before starting the study drug.
- If you or your partner could become pregnant, you agree to use reliable contraception during the study and for 6 months after finishing the study drug.
- You are willing to voluntarily take part, have fully understood the study, sign a consent form, and are able to follow and complete all study procedures.
Who may not be able to join:
- Your NMOSD is considered severe enough that the study doctor feels it would not be safe for you to participate.
- You have a long-term active immune system disease that requires ongoing treatment.
- You have received anti-CD20 therapy or other treatments that reduce certain immune cells within the past 6 months.
- You have received certain specific medications within set time periods before starting the study (confirm with trial site for details).
- You have taken part in another drug clinical trial within the past 28 days.
- You have previously received a stem cell transplant or radiation to the lymph nodes.
- You are currently pregnant, breastfeeding, or plan to have a baby during the trial.
- You had a major surgery within the 2 months before screening, or are expected to have major surgery during the trial.
- You have a severe, worsening, or uncontrolled illness that the study doctor believes puts you at higher risk.
- You have had a gastrointestinal perforation (a hole in your gut) or an abnormal internal channel (fistula) in the past 6 months.
- You received a live or weakened vaccine in the 4 weeks before starting the study, or plan to receive one during the trial.
- You currently have, or have had in the past month, a severe or ongoing infection.
- You have tested positive on a tuberculosis screening blood test (gamma interferon release test).
- You currently have active hepatitis or have a history of serious liver disease.
- You have an uncontrolled illness affecting your whole body, or any other reason the study doctor feels makes joining the trial unsuitable.
- Your laboratory (blood or urine) test results are abnormal (confirm with trial site for specific values).
- You have had a problem with alcohol or drug misuse in the past 6 months, or are currently misusing alcohol or drugs.
- You have severe mental health symptoms that make it difficult to cooperate with the study team.
- You are unable to have MRI (magnetic resonance imaging) scans during the study, or have any other condition the study doctor feels makes participation unsuitable.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 0086-010-59978555
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Time to first NMOSD Attack During RCP
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.